9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit

Law360, New York (June 14, 2011, 5:58 PM EDT) -- A group of pharmacies last week lost a bid to have the Ninth Circuit reconsider the dismissal of a suit alleging the $68 billion merger of Pfizer Inc. and Wyeth in 2009 raised prices and hurt competition in the pharmaceutical market.

The Ninth Circuit issued an order June 7 refusing to reconsider its May ruling upholding the dismissal of the suit, saying the complaint failed to support allegations of “significant anti-competitive effects."

The seven plaintiffs, including Golden Gate Pharmacy Services Inc., Marin Apothecaries and Pediatric Care...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Golden Gate Pharmacy Services, Inc. et al v. Pfizer, Inc. et al


Case Number

3:09-cv-03854

Court

California Northern

Nature of Suit

Anti-Trust

Judge

Maxine M. Chesney

Date Filed

August 21, 2009

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.